Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Aug;68(2):388–398. doi: 10.1172/JCI110267

Nature of the immunoreactive neurophysins in ectopic vasopressin-producing oat cell carcinomas of the lung. Demonstration of a putative common precursor to vasopressin and neurophysin.

T Yamaji, M Ishibashi, S Katayama
PMCID: PMC370810  PMID: 6267103

Abstract

In an attempt to delineate the nature of the immunoreactive neurophysins in oat cell carcinomas of the lung with ectopic vasopressin production, tumor neurophysins were characterized by gel filtration and by electrophoresis. In all of the five tumor tissues, activities of both vasopressin and nicotine-stimulated neurophysin (NSN) determined by radioimmunoassay were demonstrated. A small amount of oxytocin as well as estrogen-stimulated neurophysin was detected in three of the tissues. When tissue extract was subjected to Sephadex G-50 gel filtration in 0.2 N acetic acid, the major portion of immunoreactive NSN emerged in the fractions corresponding to the molecular size of 10,000. The migration pattern of NSN in these fractions on electrophoresis was qualitatively the same as that of NSN extracted from human posterior pituitary glands. In addition to this major neurophysin, immunoreactive NSN with the molecular size of 20,000 was consistently demonstrated in three tumor extracts. This high molecular weight form of neurophysin represented 6.5--8.7% of total NSN immunoactivities in each tumor extract and its elution profile was not changed when analyzed under denaturating conditions in 6 M guanidine hydrochloride. On electrophoresis, it migrated near the gamma globulin region; however, the peak was broad suggesting that it consists of more than two different molecular populations. A substantial portion of the high molecular weight NSN appears to be a glycoprotein judging from its binding to concanavalin A. When the high molecular weight from of neurophysin was incubated with trypsin, essentially all of the activities were converted into NSN with the molecular size of 10,000. Moreover, an equimolar amount of vasopressin was liberated after the treatment, the elution pattern of which closely resembled that of synthetic arginine vasopressin. When a lower concentration of trypsin was used, some of the 20,000-dalton neurophysin exhibited activities of both NSN and vasopressin. Since the antivasopressin serum used in this study appeared to be directed toward the ring portion side of vasopressin, these results suggest that this 20,000-dalton neurophysin is, in all probability, a common precursor to vasopressin and neurophysin, and that vasopressin may be located in the middle of the precursor molecule.

Full text

PDF
388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMATRUDA T. T., Jr, MULROW P. J., GALLAGHER J. C., SAWYER W. H. CARCINOMA OF THE LUNG WITH INAPPROPRIATE ANTIDIURESIS. DEMONSTRATION OF ANTIDIURETIC-HORMONE-LIKE ACTIVITY IN TUMOR EXTRACT. N Engl J Med. 1963 Sep 12;269:544–549. doi: 10.1056/NEJM196309122691102. [DOI] [PubMed] [Google Scholar]
  2. Brownstein M. J., Gainer H. Neurophysin biosynthesis in normal rats and in rats with hereditary diabetes insipidus. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4046–4049. doi: 10.1073/pnas.74.9.4046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brownstein M. J., Robinson A. G., Gainer H. Immunological identification of rat neurophysin precursors. Nature. 1977 Sep 15;269(5625):259–261. doi: 10.1038/269259a0. [DOI] [PubMed] [Google Scholar]
  4. Brownstein M. J., Russell J. T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science. 1980 Jan 25;207(4429):373–378. doi: 10.1126/science.6153132. [DOI] [PubMed] [Google Scholar]
  5. Cheng K. W., Friesen H. G. The isolation and characterization of human neurophysin. J Clin Endocrinol Metab. 1972 Jan;34(1):165–176. doi: 10.1210/jcem-34-1-165. [DOI] [PubMed] [Google Scholar]
  6. Foss Irene, Sletten Knut, Trygstad Olav. Studies on the primary structure and biological activity of a human neurophysin. FEBS Lett. 1973 Mar 1;30(2):151–156. doi: 10.1016/0014-5793(73)80640-4. [DOI] [PubMed] [Google Scholar]
  7. Gainer H., Sarne Y., Brownstein M. J. Neurophysin biosynthesis: conversion of a putative precursor during axonal transport. Science. 1977 Mar 25;195(4284):1354–1356. doi: 10.1126/science.65791. [DOI] [PubMed] [Google Scholar]
  8. George J. M., Capen C. C., Phillips A. S. Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic carcinoma. Patient with the syndrome of inappropriate secretion of antidiuretic hormone. J Clin Invest. 1972 Jan;51(1):141–148. doi: 10.1172/JCI106784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Giudice L. C., Chaiken I. M. Cell-free biosynthesis of different high molecular weight forms of bovine neurophysins I and II coded by hypothalamic mRNA. J Biol Chem. 1979 Dec 10;254(23):11767–11770. [PubMed] [Google Scholar]
  10. Giudice L. C., Chaiken I. M. Immunological and chemical identification of a neurophysin-containing protein coded by messenger RNA from bovine hypothalamus. Proc Natl Acad Sci U S A. 1979 Aug;76(8):3800–3804. doi: 10.1073/pnas.76.8.3800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Habener J. F., Kronenberg H. M. Parathyroid hormone biosynthesis: structure and function of biosynthetic precursors. Fed Proc. 1978 Oct;37(12):2561–2566. [PubMed] [Google Scholar]
  12. Hamilton B. P., Upton G. V., Amatruda T. T., Jr Evidence for the presence of neurophysin in tumors producing the syndrome of inappropriate antidiuresis. J Clin Endocrinol Metab. 1972 Nov;35(5):764–767. doi: 10.1210/jcem-35-5-764. [DOI] [PubMed] [Google Scholar]
  13. Hollenberg M. D., Hope D. B. The isolation of the native hormone-binding proteins from bovine pituitary posterior lobes. Crystallization of neurophysin-I and-II as complexes with [8-arginine]-vasopressin. Biochem J. 1968 Jan;106(2):557–564. doi: 10.1042/bj1060557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kemmler W., Steiner D. F., Borg J. Studies on the conversion of proinsulin to insulin. 3. Studies in vitro with a crude secretion granule fraction isolated from rat islets of Langerhans. J Biol Chem. 1973 Jul 10;248(13):4544–4551. [PubMed] [Google Scholar]
  15. Lauber M., Camier M., Cohen P. Immunological and biochemical characterization of distinct high molecular weight forms of neurophysin and somatostatin in mouse hypothalamus extracts. FEBS Lett. 1979 Jan 15;97(2):343–347. doi: 10.1016/0014-5793(79)80118-0. [DOI] [PubMed] [Google Scholar]
  16. Legros J. J. The radioimmunoassay of human neurophysins: contribution to the understanding of the physiopathology of neurohypophyseal function. Ann N Y Acad Sci. 1975 Feb 21;248:281–303. doi: 10.1111/j.1749-6632.1975.tb34192.x. [DOI] [PubMed] [Google Scholar]
  17. Pettengill O. S., Faulkner C. S., Wurster-Hill D. H., Maurer L. H., Sorenson G. D., Robinson A. G., Zimmerman E. A. Isolation and characterization of a hormone-producing cell line from human small cell anaplastic carcinoma of the lung. J Natl Cancer Inst. 1977 Mar;58(3):511–518. doi: 10.1093/jnci/58.3.511. [DOI] [PubMed] [Google Scholar]
  18. Robinson A. G. Isolation, assay, and secretion of individual human neurophysins. J Clin Invest. 1975 Feb;55(2):360–367. doi: 10.1172/JCI107939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Russell J. T., Brownstein M. J., Gainer H. Trypsin liberates an arginine vasopressin-like peptide and neurophysin from a Mr 20,000 putative common precursor. Proc Natl Acad Sci U S A. 1979 Dec;76(12):6086–6090. doi: 10.1073/pnas.76.12.6086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SACHS H., TAKABATAKE Y. EVIDENCE FOR A PRECURSOR IN VASOPRESSIN BIOSYNTHESIS. Endocrinology. 1964 Dec;75:943–948. doi: 10.1210/endo-75-6-943. [DOI] [PubMed] [Google Scholar]
  21. SCHWARTZ W. B., BENNETT W., CURELOP S., BARTTER F. C. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med. 1957 Oct;23(4):529–542. doi: 10.1016/0002-9343(57)90224-3. [DOI] [PubMed] [Google Scholar]
  22. Sachs H., Fawcett P., Takabatake Y., Portanova R. Biosynthesis and release of vasopressin and neurophysin. Recent Prog Horm Res. 1969;25:447–491. doi: 10.1016/b978-0-12-571125-8.50013-2. [DOI] [PubMed] [Google Scholar]
  23. Schmale H., Leipold B., Richter D. Cell-free translation of bovine hypothalamic mRNA. Synthesis and processing of the prepro-neurophysin I and II. FEBS Lett. 1979 Dec 15;108(2):311–316. doi: 10.1016/0014-5793(79)80553-0. [DOI] [PubMed] [Google Scholar]
  24. Shimamoto K., Murase T., Yamaji T. A heterologous radioimmunoassay for arginine vasopressin. J Lab Clin Med. 1976 Feb;87(2):338–344. [PubMed] [Google Scholar]
  25. Spiro R. G. Glycoproteins. Annu Rev Biochem. 1970;39:599–638. doi: 10.1146/annurev.bi.39.070170.003123. [DOI] [PubMed] [Google Scholar]
  26. Yamaji T., Ishibashi M., Kosaka K., Yanaihara T. Serum levels of neurophysin in pregnancy and in the postpartum period: relation to 17beta-estradiol levels. Metabolism. 1979 Jun;28(6):619–623. doi: 10.1016/0026-0495(79)90013-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES